Novartis | 販売および管理費



Selling And Administration Expenses 変化する 日付
AbbVie USD 3.25B 40M 2025-06
Alcon AG USD 813M 11M 2025-03
Almirall EUR 91.3M 55.52M 2025-03
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 5.01B 1.42B 2025-06
Autolus Therapeutics Ltd 29.53M 4.14M 2025-03
Bayer EUR 3.71B 628M 2025-03
Biogen USD 583.8M 11.3M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Fresenius EUR 643M 126M 2025-03
Fresenius Medical Care EUR 792M 41M 2025-06
Galapagos EUR 30.67M 13.12M 2025-06
Genmab DKK 126M 1.12B 2025-03
Gilead Sciences USD 1.36B 100M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
GRIFOLS EUR 282.76M 41.9M 2025-06
Hikma Pharmaceutical USD 288M 8M 2024-12
J&J USD 5.89B 777M 2025-06
Merck EUR 1.48B 9M 2025-06
Merck USD 2.63B 104M 2025-06
Novartis USD 3.44B 384M 2025-06
Novartis USD 3.5B 368M 2024-12
Novo Nordisk 18.85B 2.74B 2025-06
Orion EUR 96.7M 12.4M 2025-06
Pfizer USD 3.42B 406M 2025-06
Philips EUR 1.24B 9M 2025-06
Recordati EUR 186.98M 5.59M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.63B 408M 2025-06
UCB EUR 1.29B 221M 2024-12


Novartis 販売および管理費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Aug 2025.